Edition:
United States

NovaBay Pharmaceuticals Inc (NBY.A)

NBY.A on American Stock Exchange

4.50USD
20 Oct 2017
Change (% chg)

$0.05 (+1.12%)
Prev Close
$4.45
Open
$4.40
Day's High
$4.50
Day's Low
$4.40
Volume
1,622
Avg. Vol
3,854
52-wk High
$5.05
52-wk Low
$2.35

Latest Key Developments (Source: Significant Developments)

NovaBay Pharma sees FY 2017 sales $19 mln
Thursday, 10 Aug 2017 04:05pm EDT 

Aug 10 (Reuters) - NovaBay Pharmaceuticals Inc ::NovaBay Pharmaceuticals reports second quarter 2017 financial results.Q2 loss per share $0.11.Sees FY 2017 sales $19 million.Q2 sales $4.1 million versus I/B/E/S view $4.3 million.Q2 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S.NovaBay Pharmaceuticals Inc says NovaBay is affirming total sales and gross profit margin guidance for 2017.  Full Article

Novabay pharmaceuticals announces CFO transition
Monday, 10 Jul 2017 06:50am EDT 

July 10 (Reuters) - Novabay Pharmaceuticals Inc ::Novabay Pharmaceuticals announces cfo transition.Says Jack Mcgovern appointed CFO.Novabay Pharmaceuticals Inc - ‍current CFO Tom Paulson to retire at year end​.  Full Article

Novabay Pharmaceuticals reports Q1 loss per share $0.26
Thursday, 11 May 2017 04:05pm EDT 

May 11 (Reuters) - Novabay Pharmaceuticals Inc :Novabay Pharmaceuticals reports first quarter 2017 financial results.Q1 loss per share $0.26.Q1 sales $3.7 million versus I/B/E/S view $3.9 million.Q1 earnings per share view $-0.12 -- Thomson Reuters I/B/E/S.Novabay Pharmaceuticals Inc says expect current financial resources to be sufficient to fund operations and our growth strategy throughout 2017.Novabay Pharmaceuticals Inc says for Q1 Avenova prescription sales into pharmacy channel were $2.8 million, up 402% year-over-year.Novabay -Total number of medical professionals who have prescribed Avenova exceeded 9,700, up 33% year-over-year and up 12% from Q4 of 2016.Novabay Pharmaceuticals Inc says affirming its financial guidance for 2017.FY2017 earnings per share view $-0.40, revenue view $19.2 million -- Thomson Reuters I/B/E/S.  Full Article

Novabay Pharmaceuticals sees FY 2017 revenue $19 million
Thursday, 23 Mar 2017 04:05pm EDT 

Novabay Pharmaceuticals Inc : Novabay Pharmaceuticals reports 2016 full year and fourth quarter financial results and provides 2017 financial guidance . Q4 sales rose 149 percent to $4.1 million . Q4 loss per share $0.11 . Sees FY 2017 revenue up 60 percent . Sees FY 2017 revenue $19 million . Novabay Pharmaceuticals Inc- Sees 2017 net loss of $6.2 million, excluding effect of non-cash gain on change in fair value of warrant liability .Novabay Pharmaceuticals Inc- Sees 2017 cash burn of $3 million.  Full Article

NovaBay Pharmaceuticals posts Q2 loss per share $0.36
Thursday, 11 Aug 2016 04:05pm EDT 

NovaBay Pharmaceuticals Inc : NovaBay Pharmaceuticals reports 2016 second quarter financial results . Q2 loss per share $0.36 . Q2 sales rose 164 percent to $2.7 million .Says affirms outlook to reach positive cash flow from operations in December 2016.  Full Article

Novabay Pharmaceuticals appoints Mark Sieczkarek president and CEO
Monday, 13 Jun 2016 06:50am EDT 

Novabay Pharmaceuticals Inc : On track to achieve target of positive cash flow from operations by end of 2016 & accelerated revenue growth beyond . Mark Sieczkarek has served as co's interim president and ceo since november 2015 .Novabay pharmaceuticals appoints Mark M. Sieczkarek president and chief executive officer.  Full Article

Novabay Pharmaceuticals files for offering of 581,423 shares of common stock issuable upon exercise of outstanding warrants
Thursday, 9 Jun 2016 05:55pm EDT 

Novabay Pharmaceuticals Inc :Files for offering of 581,423 shares of co's common stock issuable upon exercise of outstanding warrants.  Full Article

Novabay Pharmaceuticals reports Q1 loss per share $1.24
Thursday, 12 May 2016 04:05pm EDT 

Novabay Pharmaceuticals Inc : Says affirms outlook to reach positive cash flow from operations by end of 2016 .Q1 loss per share $1.24.  Full Article

NovaBay Pharmaceuticals Inc announces $2.83 mln private placement
Wednesday, 24 Feb 2016 04:48pm EST 

NovaBay Pharmaceuticals Inc:Announces $2.83 million private placement.Says Novabay chairman and interim president and CEO Mark M. Sieczkarek also participated in the private placement.  Full Article

NovaBay Pharmaceuticals says secured $3 mln bridge loan
Thursday, 7 Jan 2016 07:00am EST 

NovaBay Pharmaceuticals:Says co has secured a $3 million bridge loan.Novabay pharmaceuticals-co has already received approximately $1.66 million, with the remaining approximate $1.37 million to be funded later this month.Says loan has a three-year term with no pre-payment penalty.  Full Article

BRIEF-Novabay pharmaceuticals announces CFO transition

* Novabay Pharmaceuticals Inc - ‍current CFO Tom Paulson to retire at year end​ Source text for Eikon: Further company coverage: